Skip to main content
. 2023 Jun 18;15(6):1761. doi: 10.3390/pharmaceutics15061761
ADC Antibody–Drug Conjugate
mAb Monoclonal Antibody
HER Human Epidermal Growth Factor
TZM Trastuzumab
CAGR Compound Annual Growth Rate
ADCC Antibody-Dependent Cell-Mediated Cytotoxicity
CDC Complement-Dependent Cytotoxicity
MRI Magnetic Resonance Imaging
CT Computer Tomography
ACNP Antibody-Conjugated Nanoparticle
NPDC Nanoparticle–Drug Conjugate
PDUFA Prescription Drug User Fee Act
ROI Return of Investment
NME New Molecular Entity
M&A Mergers and Acquisitions
PBF Project-Based Firm
PNO Project Network Organization